{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:52:19Z","timestamp":1770817939519,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/2050-6511-13-18","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T23:27:28Z","timestamp":1355959648000},"source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study"],"prefix":"10.1186","volume":"13","author":[{"given":"Thomas","family":"Babcock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Dirks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Adeyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Scheckner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,19]]},"reference":[{"issue":"4","key":"109_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","volume":"163","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K: The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006, 163 (4): 716-10.1176\/appi.ajp.163.4.716.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"109_CR2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/01.chi.0000215326.51175.eb","volume":"45","author":"SR Pliszka","year":"2006","unstructured":"Pliszka SR, Crismon ML, Hughes CW, Conners CK, Emslie GJ, Jensen PS, McCracken JT, Swanson JM, Lopez M, The Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention-Deficit\/Hyperactivity Disorder: The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006, 45 (6): 642-10.1097\/01.chi.0000215326.51175.eb.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"109_CR3","unstructured":"Canadian ADHD Resource Alliance: Canadian ADHD practice guidelines. CAP-guidelines 3rd edition. http:\/\/www.caddra.ca\/cms4\/pdfs\/caddraGuidelines2011.pdf . Accessed September 13, 2012"},{"issue":"1","key":"109_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/0269881106073219","volume":"21","author":"DJ Nutt","year":"2007","unstructured":"Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, Morris KA, Santosh P, Sonuga-Barke E, Taylor E: Evidence-based guidelines for management of attention-deficit\/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2007, 21 (1): 10-","journal-title":"J Psychopharmacol"},{"issue":"4","key":"109_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/108705470000300403","volume":"3","author":"LE Arnold","year":"2000","unstructured":"Arnold LE: Methylphenidate vs. amphetamine: comparative review. J Atten Disord. 2000, 3 (4): 200-10.1177\/108705470000300403.","journal-title":"J Atten Disord"},{"key":"109_CR6","volume-title":"Poster Presented at: American College of Neuropsychopharmacology's 42nd Annual Meeting; December 7-11","author":"WJ Burke","year":"2003","unstructured":"Burke WJ, Bose A, Wang J, Stahl SM: Switching depressed patients from citalopram to escitalopram is well tolerated and effective. Poster Presented at: American College of Neuropsychopharmacology's 42nd Annual Meeting; December 7-11. 2003, San Juan, Puerto Rico"},{"issue":"12","key":"109_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMoa052963","volume":"354","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF: Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006, 354 (12): 1231-10.1056\/NEJMoa052963.","journal-title":"N Engl J Med"},{"issue":"8","key":"109_CR8","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/00004583-199608000-00008","volume":"35","author":"DP Cantwell","year":"1996","unstructured":"Cantwell DP: Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1996, 35 (8): 978-10.1097\/00004583-199608000-00008.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"109_CR9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1542\/peds.86.2.226","volume":"86","author":"W Pelham Jr","year":"1990","unstructured":"Pelham W, Greenslade KE, Vodde-Hamilton M, Murphy DA, Greenstein JJ, Gnagy EM, Guthrie KJ, Hoover MD, Dahl RE: Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics. 1990, 86 (2): 226-","journal-title":"Pediatrics"},{"issue":"4","key":"109_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1089\/cap.2004.14.542","volume":"14","author":"LE Arnold","year":"2004","unstructured":"Arnold LE, Lindsay RL, Conners CK, Wigal SB, Levine AJ, Johnson DE, West SA, Sangal RB, Bohan TP, Zeldis JB: A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2004, 14 (4): 542-10.1089\/cap.2004.14.542.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"109_CR11","unstructured":"Vyvanse [package insert]. 2012, Wayne, PA: Shire US Inc"},{"issue":"1","key":"109_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2147\/NDT.S9749","volume":"6","author":"M Pennick","year":"2010","unstructured":"Pennick M: Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat. 2010, 6 (1): 317-","journal-title":"Neuropsychiatr Dis Treat"},{"key":"109_CR13","unstructured":"Adderall XR [package insert]. 2011, Wayne, PA: Shire US Inc"},{"key":"109_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1744-9081-6-34","volume":"6","author":"T Wigal","year":"2010","unstructured":"Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J, on behalf of the 316 Study Group: Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder: novel findings using the adult workplace environment design. Behav Brain Funct. 2010, 6: 34-10.1186\/1744-9081-6-34.","journal-title":"Behav Brain Funct"},{"issue":"10","key":"109_CR15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1017\/S1092852900024056","volume":"14","author":"R Weisler","year":"2009","unstructured":"Weisler R, Young J, Mattingly G, Gao J, Squires L, Adler L, on behalf of the 304 Study Group: Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder. CNS Spectr. 2009, 14 (10): 573-","journal-title":"CNS Spectr"},{"issue":"9","key":"109_CR16","first-page":"44","volume":"17","author":"R Lasser","year":"2010","unstructured":"Lasser R, Dirks B, Adeyi B, Babcock T: Comparative efficacy and safety of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in adults with attention-deficit\/hyperactivity disorder. Prim Psychiatr. 2010, 17 (9): 44-","journal-title":"Prim Psychiatr"},{"issue":"12 suppl 20","key":"109_CR17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1017\/S1092852900002406","volume":"10","author":"J Biederman","year":"2005","unstructured":"Biederman J, Spencer TJ, Wilens TE, Weisler RH, Read SC, Tulloch SJ, on behalf of the SLI 381.304 Study Group: Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr. 2005, 10 (12 suppl 20): 16-","journal-title":"CNS Spectr"},{"issue":"8","key":"109_CR18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S1092852900013687","volume":"11","author":"RH Weisler","year":"2006","unstructured":"Weisler RH, Biederman J, Spencer TJ, Wilens TE, Faraone SV, Chrisman AK, Read SC, Tulloch SJ, on behalf of the SLI381.303 Study Group: Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006, 11 (8): 625-","journal-title":"CNS Spectr"},{"issue":"5","key":"109_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3810\/pgm.2009.09.2048","volume":"121","author":"MB Haffey","year":"2009","unstructured":"Haffey MB, Buckwalter M, Zhang P, Homolka R, Martin P, Lasseter KC, Ermer JC: Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults. Postgrad Med. 2009, 121 (5): 11-10.3810\/pgm.2009.09.2048.","journal-title":"Postgrad Med"},{"issue":"9","key":"109_CR20","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.4088\/JCP.v69n0903","volume":"69","author":"LA Adler","year":"2008","unstructured":"Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, Biederman J, on behalf of the 303 Study Group: Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder. J Clin Psychiatry. 2008, 69 (9): 1364-10.4088\/JCP.v69n0903.","journal-title":"J Clin Psychiatry"},{"key":"109_CR21","volume-title":"Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. 2000, Washington, DC: American Psychiatric Association"},{"key":"109_CR22","volume-title":"ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation","author":"GJ DuPaul","year":"1998","unstructured":"DuPaul GJ, Power TJ, Anastopoulos AD, Reid R: ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. 1998, New York, NY: Guilford Press"},{"issue":"2","key":"109_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.psc.2003.12.003","volume":"27","author":"L Adler","year":"2004","unstructured":"Adler L, Cohen J: Diagnosis and evaluation of adults with attention-deficit\/hyperactivity disorder. Psychiatr Clin North Am. 2004, 27 (2): 187-10.1016\/j.psc.2003.12.003.","journal-title":"Psychiatr Clin North Am"},{"key":"109_CR24","first-page":"218","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"W Guy","year":"1976","unstructured":"Guy W: Clinical global impressions. ECDEU Assessment Manual for Psychopharmacology. 1976, Rockville, MD: US Department of Health, Education, and Welfare; Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch, 218-222."},{"issue":"5","key":"109_CR25","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1542\/peds.112.5.e404","volume":"112","author":"MA Stein","year":"2003","unstructured":"Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH: A dose-response study of OROS methylphenidate in children with attention-deficit\/hyperactivity disorder. Pediatrics. 2003, 112 (5): e404-10.1542\/peds.112.5.e404.","journal-title":"Pediatrics"},{"issue":"11","key":"109_CR26","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.clinthera.2006.11.006","volume":"28","author":"M Steele","year":"2006","unstructured":"Steele M, Jensen PS, Quinn DMP: Remission versus response as the goal of therapy in ADHD: a new standard for the field?. Clin Ther. 2006, 28 (11): 1892-10.1016\/j.clinthera.2006.11.006.","journal-title":"Clin Ther"},{"issue":"2","key":"109_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/00004583-200102000-00011","volume":"40","author":"JM Swanson","year":"2001","unstructured":"Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, Clevenger W, Davies M, Elliott GR, Greenhill LL: Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001, 40 (2): 168-10.1097\/00004583-200102000-00011.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"109_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0165-1781(91)90126-A","volume":"36","author":"J Elia","year":"1991","unstructured":"Elia J, Borcherding BG, Rapoport JL, Keysor CS: Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?. Psychiatry Res. 1991, 36 (2): 141-10.1016\/0165-1781(91)90126-A.","journal-title":"Psychiatry Res"},{"issue":"3","key":"109_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00213-006-0550-9","volume":"191","author":"BM Joyce","year":"2007","unstructured":"Joyce BM, Glaser PE, Gerhardt GA: Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers. Psychopharmacology (Berl). 2007, 191 (3): 669-10.1007\/s00213-006-0550-9.","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"109_CR30","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1177\/0091270009357346","volume":"50","author":"J Ermer","year":"2010","unstructured":"Ermer J, Homolka R, Martin P, Buckwalter M, Purkayastha J, Roesch B: Lisdexamfetamine dimesylate: linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteers. J Clin Pharmacol. 2010, 50 (9): 1001-10.1177\/0091270009357346.","journal-title":"J Clin Pharmacol"},{"key":"109_CR31","first-page":"740","volume-title":"Poster Presented at: 160th Annual Meeting of the American Psychiatric Association; May 19-24","author":"A Shojaei","year":"2007","unstructured":"Shojaei A, Ermer JC, Krishnan S: Lisdexamfetamine dimesylate as a treatment for ADHD: dosage formulation and pH effects. Poster Presented at: 160th Annual Meeting of the American Psychiatric Association; May 19-24. 2007, San Diego, CA: Poster NR, 740-"},{"issue":"3","key":"109_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/0091270007310381","volume":"48","author":"S Krishnan","year":"2008","unstructured":"Krishnan S, Zhang Y: Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic study. J Clin Pharmacol. 2008, 48 (3): 293-10.1177\/0091270007310381.","journal-title":"J Clin Pharmacol"},{"key":"109_CR33","volume-title":"Poster Presented at: New Clinical Drug Evaluation Unit Annual Meeting; June 13-16","author":"H Rowley","year":"2011","unstructured":"Rowley H, Heal D, Hackett D: Simultaneous measurement with hysteresis analyses of the effects of lisdexamfetamine dimesylate and d-amphetamine on striatal levels of extracellular dopamine, locomotor activity, and plasma drug concentrations in freely-moving rats. Poster Presented at: New Clinical Drug Evaluation Unit Annual Meeting; June 13-16. 2011, Boca Raton, FL"},{"issue":"2 suppl","key":"109_CR34","doi-asserted-by":"publisher","first-page":"26S","DOI":"10.1097\/00004583-200202001-00003","volume":"41","author":"LL Greenhill","year":"2002","unstructured":"Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J: Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002, 41 (2 suppl): 26S-","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"109_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1753-2000-5-35","volume":"5","author":"R Jain","year":"2011","unstructured":"Jain R, Babcock T, Burtea T, Dirks B, Adeyi B, Scheckner B, Lasser R: Efficacy of lisdexamfetamine dimesylate in children with attention-deficit\/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis. Child Adolesc Psychiatry Ment Health. 2011, 5 (1): 35-10.1186\/1753-2000-5-35.","journal-title":"Child Adolesc Psychiatry Ment Health"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2050-6511-13-18\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-13-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-13-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-13-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T22:44:46Z","timestamp":1643928286000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/2050-6511-13-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["109"],"URL":"https:\/\/doi.org\/10.1186\/2050-6511-13-18","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"article-number":"18"}}